Optimizing treatment strategies in paediatric atypical hemolytic uremic syndrome

Pediatric Nephrology

Volumn 26, Issue 10, 2011, Pages 1917-1918

  Waters, Aoife ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COMPLEMENT FACTOR H; ECULIZUMAB; FRESH FROZEN PLASMA;

ATYPICAL HAEMOLYTIC URAEMIC SYNDROME; ATYPICAL HEMOLYTIC UREMIC SYNDROME; CHILDHOOD DISEASE; CHROMOSOME 1Q; DRUG EFFICACY; GENE CLUSTER; GENE LOCUS; GENE MAPPING; GENOTYPE; HEART FAILURE; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HOMEOSTASIS; HYPERLIPOPROTEINEMIA; HYPERTENSION; HYPOVOLEMIA; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LETTER; LONG TERM CARE; MUTATION; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT PLANNING; VASCULAR ACCESS;

ANTIBODIES, MONOCLONAL; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNOLOGIC FACTORS;

EID: 80052302283     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1930-x     Document Type: Letter

References (3)

1. Davin JC, Groothoff J, Gracchi V, Bouts A (2011) Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome. Pediatr Nephrol. doi: 10.1007/s00467-011-1925-7
2. AM Waters C Licht 2011 aHUS caused by complement dysregulation: new therapies on the horizon Pediatr Nephrol 26 41 57 20556434 10.1007/s00467-010- 1556-4
3. AL Lapeyraque V Frémeaux-Bacchi P Robitaille 2011 Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome Pediatr Nephrol 26 621 4 21161283 10.1007/s00467-010-1719-3